» Articles » PMID: 36135559

Sr and Mg Doped Bi-Phasic Calcium Phosphate Macroporous Bone Graft Substitutes Fabricated by Robocasting: A Structural and Cytocompatibility Assessment

Abstract

Bi-phasic calcium phosphates (BCPs) are considered prominent candidate materials for the fabrication of bone graft substitutes. Currently, supplemental cation-doping is suggested as a powerful path to boost biofunctionality, however, there is still a lack of knowledge on the structural role of such substituents in BCPs, which in turn, could influence the intensity and extent of the biological effects. In this work, pure and Mg- and Sr-doped BCP scaffolds were fabricated by robocasting from hydrothermally synthesized powders, and then preliminarily tested and thoroughly investigated physically and chemically. Collectively, the osteoblast cell culture assays indicated that all types of BCP scaffolds (pure, Sr- or Sr-Mg-doped) delivered performances similar to the biological control, with emphasis on the Sr-Mg-doped ones. An important result was that double Mg-Sr doping obtained the ceramic with the highest -tricalcium phosphate (-TCP)/hydroxyapatite mass concentration ratio of ~1.8. Remarkably, Mg and Sr were found to be predominantly incorporated in the -TCP lattice. These findings could be important for the future development of BCP-based bone graft substitutes since the higher dissolution rate of -TCP enables an easier release of the therapeutic ions. This may pave the road toward medical devices with more predictable performance.

Citing Articles

Binary Doping of Strontium-Magnesium to Bioactive Glasses to Enhance Antibacterial and Osteogenic Effects.

Li Z, Li Z, Wang J, Liao L, Li X, Zhang Z ACS Omega. 2025; 10(1):215-229.

PMID: 39829480 PMC: 11739949. DOI: 10.1021/acsomega.4c04898.


Two decades of continuous progresses and breakthroughs in the field of bioactive ceramics and glasses driven by CICECO-hub scientists.

Fernandes H, Kannan S, Alam M, Stan G, Popa A, Buczynski R Bioact Mater. 2024; 40:104-147.

PMID: 39659434 PMC: 11630650. DOI: 10.1016/j.bioactmat.2024.05.041.


Evaluation of Biphasic Calcium Phosphate Scaffolds Derived from Cuttlefish Bone Coated with Poly(ester urea) for Bone Tissue Regeneration.

Pereira P, S Neto A, Rodrigues A, Barros I, Miranda C, Ramalho-Santos J Polymers (Basel). 2023; 15(10).

PMID: 37242831 PMC: 10220552. DOI: 10.3390/polym15102256.


Clindamycin-Loaded Nanosized Calcium Phosphates Powders as a Carrier of Active Substances.

Slota D, Pietak K, Florkiewicz W, Jampilek J, Tomala A, Urbaniak M Nanomaterials (Basel). 2023; 13(9).

PMID: 37177013 PMC: 10180150. DOI: 10.3390/nano13091469.


Multi-Parametric Exploration of a Selection of Piezoceramic Materials for Bone Graft Substitute Applications.

Nedelcu L, Ferreira J, Popa A, Amarande L, Nan B, Balescu L Materials (Basel). 2023; 16(3).

PMID: 36769908 PMC: 9917895. DOI: 10.3390/ma16030901.


References
1.
Touri M, Moztarzadeh F, Abu Osman N, Dehghan M, Mozafari M . 3D-printed biphasic calcium phosphate scaffolds coated with an oxygen generating system for enhancing engineered tissue survival. Mater Sci Eng C Mater Biol Appl. 2018; 84:236-242. DOI: 10.1016/j.msec.2017.11.037. View

2.
Bose S, Fielding G, Tarafder S, Bandyopadhyay A . Understanding of dopant-induced osteogenesis and angiogenesis in calcium phosphate ceramics. Trends Biotechnol. 2013; 31(10):594-605. PMC: 3825404. DOI: 10.1016/j.tibtech.2013.06.005. View

3.
Manjubala I, Sastry T, Suresh Kumar R . Bone in-growth induced by biphasic calcium phosphate ceramic in femoral defect of dogs. J Biomater Appl. 2005; 19(4):341-60. DOI: 10.1177/0885328205048633. View

4.
de Oliveira Puttini I, Poli P, Maiorana C, Vasconcelos I, Schmidt L, Colombo L . Evaluation of Osteoconduction of Biphasic Calcium Phosphate Ceramic in the Calvaria of Rats: Microscopic and Histometric Analysis. J Funct Biomater. 2019; 10(1). PMC: 6462940. DOI: 10.3390/jfb10010007. View

5.
Klontzas M, Kenanidis E, Macfarlane R, Michail T, Potoupnis M, Heliotis M . Investigational drugs for fracture healing: preclinical & clinical data. Expert Opin Investig Drugs. 2016; 25(5):585-96. DOI: 10.1517/13543784.2016.1161757. View